Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Vaxil Bio Ltd V.VXL

Alternate Symbol(s):  VXLLF

Vaxil Bio Ltd. is a Canada-based biotechnology company. The Company is focused on a drug discovery and development platform based on Signal Peptides (SPs) which the Company deploys to fight infectious diseases and cancer. The Company’s most advanced product, ImMucin, a MUC1 SP-derived vaccine, completed a Phase I/II clinical trial in multiple myeloma. The Company also has a SP-based COVID-19 vaccine candidate and a SP-based tuberculosis vaccine / treatment candidate. In addition, The Company has mAb candidates for the treatment of oncology and infectious diseases to be used alone, and in combination with other treatments. It has also initiated a pre-clinical program for a drug delivery polymer that targets high affinity E-selectin (P-Esbp), which the Company licensed for development and commercialization from BGN Technologies. It exploits the properties of SP domains on crucial proteins to develop targeted therapies against cancer targets and infectious disease pathogens.


TSXV:VXL - Post by User

Comment by 90guppyon May 20, 2020 7:13pm
81 Views
Post# 31053853

RE:given vxl is working with a hospital now

RE:given vxl is working with a hospital now" the toughest of the coronavirus cases in Israel go to Tel Aviv Sourasky Hospital". The same hospital that Vaxil has signed an agreement on for the clinical trials of its covid vaccine.Take a look inside the ICU

https://www.cnn.com/videos/world/2020/04/19/coronavirus-covid-19-israel-busy-icu-liebermann-pkg-vpx.cnn

Then check the clinical trials network services of Sourasky Hospital

https://www.tasmc.org.il/sites/en/Research/Clinical-Trials/Pages/Clinical-Trials.aspx

"Clinical Trials Network Services was established in 1999, and provides a comprehensive infrastructure for the performance of clinical trials in the different departments of the Tel Aviv Sourasky Medical Center. It has already completed over 30 studies for major pharmaceutical companies, like Bayer, MSD, Knoll, Astra-Zeneca, Pharmacia, and others.

The cost-effective clinical research is managed by physicians and highly trained and experienced nurses.

CTNS provides assistance to principal investigators in protocol submission, patient recruitment and quality assurance coordinator backup.

CTNS facilitates trials conducted in the various hospital departments, and maintains a growing database of patients according to various clinical classifications, for fast compliance with requirements of clinical studies."


<< Previous
Bullboard Posts
Next >>